Category: Research Studies

Resistant Starch and COVID-19

RS and COVID-19

In light of the current COVID-19 Pandemic, people are actively looking for dietary ingredients and supplements that support a healthy immune system. Resistant starch supports a healthy immune system, but we do not know how it might impact people with the COVID-19 virus. Resistant starch’s fermentation in the large intestine helps keep the intestinal barrier Read More …

RS and Cardiovascular Disease

The Gut Heart Axis

A huge discovery has been made by Dr. Francine Marques and her colleagues at the Baker Heart and Diabetes Institute in Australia. A new international study demonstrated that the lack of prebiotic fiber leads to hypertension and cardiovascular disease, (Kaye, et al. Circulation 2020). I was very happy to see that they utilized resistant starch Read More …

Kidney Health

Most people are not focused on their kidneys.  From a consumer wellness perspective, kidney health isn’t a “thing” at all.  It probably should be, given the rapid growth of kidney disease in older populations. Chronic Kidney Disease (CKD) currently affects 30 million American adults, (15% of US adults).  Adults with diabetes, high blood pressure or Read More …

Childrens Resistant Starch Yogurt Study

Resistant Starch Studied in Children

Children are battling weight gain and obesity as well as adults. They have fewer options, as pharmaceutical options are much more limited in children. A new pilot study was just published in F1000 Research that lays the groundwork for resistant starch-enriched yogurt to help address this problem. And because it was published by the Pennington Read More …

Sitagliptin Synergy

Nutrient and Drug are Synergistic

Mike Keenan at Louisiana State University just published his 15th animal study with RS2 resistant starch from high amylose corn. Surprisingly, it was sponsored by Merck and examined the potential synergism between Merck’s drug Januvia® (sitagliptin) and resistant starch. Both impact GLP-1 in the gut, but by different mechanisms. Sitagliptin inhibits the breakdown of GLP-1 Read More …